• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Abbott

Former Abbott sales director’s age discrimination suit can proceed

March 5, 2021 By Sean Whooley Leave a Comment

This story was updated with a statement from Abbott. A New Jersey federal judge has ruled that an age bias lawsuit from a former sales director at Abbott (NYSE:ABT) can move forward. Richard Rudolph alleged that, after 15 years as a sales director at the Abbott Park, Ill.-based medtech company, he was let go because […]

Filed Under: Business/Financial News, Featured, Legal News Tagged With: Abbott

Abbott wins EUA for COVID-19, flu, RSV combo assay

March 5, 2021 By Sean Whooley Leave a Comment

Abbott (NYSE:ABT) announced today that it received FDA emergency use authorization (EUA) for its Alinity m Resp-4-Plex molecular assay. The laboratory PCR diagnostic is designed to detect and differentiate between SARS-CoV-2 (the virus causing COVID-19), influenza A, influenza B and respiratory syncytial virus (RSV) in one test. It already has CE Mark approval and is […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, coronavirus, COVID-19, FDA

Abbott COVID-19 serology test gains EUA

March 3, 2021 By Sean Whooley Leave a Comment

Abbott (NYSE:ABT) this week received FDA emergency use authorization (EUA) for its AdviseDx SARS-CoV-2 IgG II diagnostic — providing another tool to detect people’s adaptive immune response to COVID-19. The serology test from Abbott Park, Ill.-based Abbott is indicated for the qualitative and semi-quantitative detection of IgG antibodies to SARS-CoV-2 — the virus causing COVID-19 […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, coronavirus, COVID-19, FDA

Abbott researchers help discover a clue to an HIV cure

March 2, 2021 By Chris Newmarker Leave a Comment

Abbott announced today that a team including its scientists has uncovered a rare group of Democratic Republic of Congo residents who are HIV positive but have almost nonexistent viral loads without using antiretroviral treatments. This group of “HIV elite controllers” opens up a new area for researchers to discover biological trends that could inform the […]

Filed Under: Featured, Pharmaceutical Tagged With: Abbott, HIV/AIDs, Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), Université Protestante au Congo, University of Missouri-Kansas City

Quidel wins FDA nod for at-home antigen test

March 1, 2021 By Nancy Crotti Leave a Comment

The FDA issued an emergency use authorization today for the Quidel Corp. (NSDW:QDEL) QuickVue At-Home COVID-19 test, another antigen test to rapidly collect and test samples at home, without the need to send a sample to a laboratory for analysis. The QuickVue At-Home COVID-19 test is authorized for prescription home use with self-collected nasal swab […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Abbott, antigen test, CareEvolution, coronavirus, COVID-19, Ellume, National Institutes of Health (NIH), Quidel Corp.

DTW Podcast: Zimmer Biomet slims, Corza Medical grows in pursuit of grabbing market share

February 8, 2021 By Tom Salemi

In this week’s DeviceTalks Weekly Podcast, Rich Newitter, managing director at SVB Leerink, says Zimmer Biomet’s decision to spin out its spinal and dental business will accelerate its already impressive market share grab in its core orthopedics industry. Newitter says CEO Bryan Hanson brings a tried-and-true diversification model used by companies like his former employer, […]

Filed Under: Dental, Device Talks Podcasts, Digital Health, Featured, Lab Instruments & Supplies, Orthopedics, Spine, Surgical, Wall Street Beat Tagged With: 3m, Abbott, Abbott Laboratories, Aegea Medical, Boston Scientific, CooperSurgical, Corza Medical, Covidien, Medtronic, SVB Leerink, Zimmer Biomet

MedTech 100 roundup: Index hits another all-time high

February 8, 2021 By Sean Whooley

The beginning of February brought yet another peak for medtech stocks. MassDevice‘s MedTech 100 index ended the week (Feb. 5) at 108.23 points, marking a 4% rise from the 104.05-point mark set at the end of the previous week (Jan. 29). The final mark for the week sets an all-time best for the index, which had […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: 3m, Abbott, Align Technology, Baxter, BD, becton dickinson, Boston Scientific, Cardinal Health, Masimo, TransEnterix, Zimmer Biomet

3M, Abbott in top 50 of Fortune’s most admired companies list

February 1, 2021 By Chris Newmarker

Medtech giants  3M (NYSE:MMM) and Abbott (NYSE:ABT) made it into the top 50 of Fortune‘s 2021 World’s Most Admired Companies list. 3M — a manufacturing conglomerate that also has one of the largest medical device businesses in the world — came in at No. 24, up from No. 29 in the 2020 list. Abbott meanwhile was No. […]

Filed Under: Business/Financial News, Featured Tagged With: 3m, Abbott, Boston Scientific, Danaher Corp., Medtronic, Stryker, Thermo Fisher Scientific

MedTech 100 roundup: January ends with a dip

February 1, 2021 By Sean Whooley

After spending several weeks on the ascent, medtech stocks leveled out a bit to end January, ending a run of several new highs in 2021. MassDevice‘s MedTech 100 index ended the week (Jan. 29) at 104.05 points, marking a -2.2% drop from the 106.4-point mark set at the end of the previous week (Jan. 22). The […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: 3m, Abbott, Abiomed, coronavirus, COVID-19, Edwards Lifesciences, Hologic, Johnson & Johnson, Olympus, ResMed, Stryker, Varian Medical Systems

COVID-19 test sales boost Abbott in Street-beating Q4

January 27, 2021 By Sean Whooley

Abbott (NYSE:ABT) shares ticked up this morning on fourth-quarter results that bested the consensus forecast. The Abbott Park, Ill.-based company posted profits of $2.2 billion, or $1.20 per share, on sales of $10.7 billion for the three months ended Dec. 31, 2020, for a more than doubled bottom line on sales growth of 28.7%. Adjusted to […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Abbott, coronavirus, COVID-19

Abbott Panbio rapid antigen test wins CE mark for asymptomatic COVID-19 screening

January 26, 2021 By Sean Whooley

Abbott (NYSE:ABT) announced today that it received CE Mark for two new uses of its Panbio COVID-19 Ag rapid diagnostic. Panbio COVID-19 Ag has received an updated label with clinical data on asymptomatic individuals to enable mass testing of people who do not currently present symptoms of the disease, according to a news release. The other […]

Filed Under: Diagnostics, Featured, Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, CE Mark, coronavirus, COVID-19

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 84
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS